Frequency of Veno-occlusive Disease of the Liver in Bone Marrow Transplantation with a Modified Busulfan/Cyclophosphamide Preparative Regimen
Authors:
- 1 June 1990
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 13 (3) , 221-225
Abstract
Veno-occlusive disease (VOD) of the liver is a major complication of hone marrow transplantation (BMT). The overall frequency of VOD has ranged from 20 to 30%, with a mortality rate > 40%, as reported by centers utilizing cyclophosphamide (Cy) and total body irradiation (CyTBI) or various chemotherapeutic regimens, including the busulfan (Bu) (4 mg/kg for 4 days) and Cy (50 mg/kg for 4 days) (BuCy4) combination. Since 1986, Hahnemann University (HU) has primarily used the BuCy2 regimen, i.e., Bu (4 mg/kg for 4 days) followed by Cy (60 mg/kg for 2 days). We reviewed 74 consecutive patients who received either an autologous or allogeneic BMT for various malignancies from January 1986 through October 1988 to determine the frequency of VOD. Seven of 74 consecutive patients met clinical criteria for VOD, for a total frequency of 9.5%. Fifty-five patients were conditioned with various other regimens. Only 5 of the patients conditioned with BuCy2 developed VOD (9.1%.). This is less than the 25% reported frequency of VOD in patients who received CyTBI (1,000 rads) and less than the 24% reported frequency of VOD in patients who received BuCy4. Only one of seven patients who developed VOD died from the disease. One patient died of sepsis after the VOD had almost completely resolved. The remaining five completely recovered. We conclude that the total Cy dose, and not Bu, is the major factor in the occurrence of VOD in Bu/Cy BMT preparative regimens, and the BuCy2 regimen reduces the frequency of VOD in autologous and allogeneic graft recipients when compared to CyTBI or the BuCy4 regimens.Keywords
This publication has 14 references indexed in Scilit:
- HEPATIC VENOOCCLUSIVE DISEASE AFTER BONE-MARROW TRANSPLANTATION - IMMUNOHISTOCHEMICAL IDENTIFICATION OF THE MATERIAL WITHIN OCCLUDED CENTRAL VENULES1987
- BUSULFAN AND CYCLOPHOSPHAMIDE CAUSE LITTLE EARLY TOXICITY DURING DISPLACEMENT BONE-MARROW TRANSPLANTATION IN 50 CHILDREN1986
- Veno‐occlusive liver disease after dacarbazine therapy (DTIC) for melanomaJournal of Surgical Oncology, 1984
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983
- Veno-occlusive disease of the liver in children following chemotherapy for acute myelocytic leukemiaCancer, 1983
- PATHOGENESIS OF VENO-OCCLUSIVE LIVER-DISEASE AFTER RADIATION1980
- Anticoagulation and high dose liver radiation.A preliminary reportCancer, 1979
- Veno-Occlusive Disease of the Liver After Chemotherapy of Acute LeukemiaAnnals of Internal Medicine, 1976
- Fibrosis of central and hepatic veins, and perisinusoidal spaces of the liver following prolonged administration of urethaneThe American Journal of Medicine, 1961